IGF1R is an entry receptor for respiratory syncytial virus

Journal: Nature

Published: 2020-06-03

DOI: 10.1038/s41586-020-2369-7

Affiliations: 15

Authors: 18

Go to article
Institutions Share
Translational Medicine Research Program, SickKids U of T, Canada 0.24
Li Ka Shing Institute of Virology, U of A, Canada 0.22
Department of Medical Microbiology and Immunology (MMI), U of A, Canada 0.17
Yale Section of Pulmonary, Critical Care and Sleep Medicine, United States of America (USA) 0.06
Department of Physiology and Pharmacology, U of C, Canada 0.06
Snyder Institute for Chronic Diseases, U of C, Canada 0.06
Department of Human Genetics, KU Leuven, Belgium 0.06
Department of Cell Biology, U of A, Canada 0.06
Department of Paediatrics, U of T, Canada 0.02
Department of Laboratory Medicine and Pathobiology (LMP), U of T, Canada 0.02
St. Giles Laboratory of Human Genetics of Infectious Disease, The Rockefeller University, United States of America (USA) 0.01
Laboratory of Human Genetics of Infectious Diseases (GHMI), Imagine Institute, France 0.01
Imagine Institute, France 0.01
Hôpital Necker-Enfants Malades, France 0.01
The Rockefeller University, United States of America (USA) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER